Notícias e Atividades da Perceptive

A Perceptive pertence à Konica Minolta.

Konica Minolta é uma das ...

• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Konica Minolta é uma empresa listada sob o símbolo 4902 (JP).

Konica Minolta tem presença direta em 11 países.

Konica Minolta possui 13 subsidiárias incluindo Konica Minolta Australia, Konica Minolta Business Solutions Asia e Konica Minolta Business Solutions Canada.

Eles estão dentro:

• Equipamento de Escritório71%
• Aero espacial14%
• Outro14%

Veja o organograma con seus 23 executivos principais

Biografias mais buscadas da Perceptive

• Benjamin Murphy, Chief Executive Officer
• Sean Carlin, Senior Vice President of Scientific Strategy,
• Ilan Rabiner, Executive Vice President and Head of Translational A...

Recentes movimentos de executivos em Perceptive

• Sean Carlin, ingressou na Companhia como Senior Vice President of Scientific Strategy,  (Notícia publicada em 4 de junho de 2026).
• Madhav Vattikuti antes Senior Vice President of Technology and General Manager, India, agora é Chief Digital and Innovation Officer  (Notícia publicada em 30 de abril de 2026).
• Joeseph Vacca antes Vice President, Business Development, agora é Vice President and General Partner, Radiopharmaceuticals  (Notícia publicada em 30 de abril de 2026).

Clique aqui para ver outras movimentos em Perceptive

Criar um alerta
para seguir os movimentos de executivos da Perceptive.

Konica Minolta possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado em 15 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Robert Gould - Board Member da Fulcrum Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Perceptive

• Perceptive Discovery and Certis Oncology Announce Strategic Collaboration to Advance Radiopharmaceutical Development
• Perceptive Discovery Appoints Sean Carlin, PhD, as Senior Vice President of Scientific Strategy
• Perceptive Imaging Appoints Gregory Goldmacher as Chief Scientific & Medical Officer to Further Strengthen Scientific Leadership and Sponsor Partnership
• Perceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with Trialzen - Perceptive | Science-Led Clinical Imaging, RTSM & Adjudication
• Perceptive Discovery Announces Strategic Partnership with MH3D and Launch of α-Sight to Advance Alpha Radiopharmaceutical Imaging
• Perceptive Discovery Expands In Vitro Capabilities at Needham, MA Site to Accelerate Preclinical Oncology Research | Perceptive
• Perceptive eClinical and Kayentis partner to tackle increasing digital system complexity in global clinical trials - Perceptive | Science-Led Clinical Imaging, RTSM & Adjudication
• Perceptive Imaging Expands Executive Leadership Team to Accelerate and Advance Platform Innovation and Study Delivery Succession | Perceptive
• Atley and Perceptive Announce Strategic Collaboration Focused on Astatine-211
• Perceptive Discovery Announces Strategic Expansion | Perceptive
• View more press releases Close

Redes sociais sobre Perceptive

• Perceptive na Wikipedia, Google News e Yahoo Finance
• Perceptive na LinkedIn, X (Twitter) e YouTube